A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 Within one of the smallest regions of overlap for common deletions in breast and prostate cancers

Genes Chromosomes and Cancer

Volumn 22, Issue 1, 1998, Pages 26-36

  Filippova, Galina N ^a   Lindblom, Annika ^b   Meincke, Linda J ^c   Klenova, Elena M ^d   Neiman, Paul E ^a   Collins, Steve J ^a   Doggett, Norman A ^c   Lobanenkov, Victor V ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CHROMOSOMAL LOCALIZATION; CHROMOSOME 16Q; CHROMOSOME DELETION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; PROTO ONCOGENE; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; DNA-BINDING PROTEINS; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, OVERLAPPING; HUMANS; MALE; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031977285     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9     Document Type: Article

References (66)

1. Arthur DC, Bloomfield CD (1983) Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: A new association. Blood 61:994-998.
2. Berx G, Cleton-Jansen A-M, Strumane K, de Leeuw WJF, Nollet F, van Roy F, Cornelisse C (1996) E-cadherin is truncated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
3. Betts DR, Rohatiner AZS, Evans ML, Bassam SMB, Lister TA, Gibbons B (1992) Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukemia 6:1250-1256.
4. Blackwood EM, Eisenman RN (1991) Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with MYC. Science 251:1211-1217.
5. Burcin M, Arnold R, Lutz M, Kaiser B, Runge D, Lottspeich F, Filippova GN, Lobanenkov VV, Renkawitz R (1997) Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol 17:1281-1288.
6. Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA (1987) Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate 11:327-337.
7. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A (1997) Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93.
8. Callen DF, Doggett NA, Stallings RL, Chen LZ, VVhitmore SA, Lane SA, Nancarrow JK, Apostolou S, Thompson AD, Lapsys NM, Eyre HJ, Baker EG, Shen Y, Holman K, Phillips H, Richards RI, Sutherland GR (1992) High resolution cytogenetic-based physical map of human chromosome 16. Genomics 13:1178-1185.
9. Callen DF, Lane SA, Kozman H, Kremmidiotis G, Whitmore SA, Lowenstein M, Doggett NA, Kenmochi N, Page DC, Maglott DR, Nierman WC, Murakawa K, Berry R, Sikela JM, Houlgatte R, Auffray C, Sutherland GR (1995) Integration of transcript and genetic maps of chromosome 16 at near-1-Mb resolution: Demonstration of a "hot spot" for recombination at 16p12. Genomics 29:503-511.
10. Campbell LJ, Challis J, Fok T, Garson OM (1991) Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromosomes Cancer 3:55-61.
11. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990) Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
12. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal Biochem 162:156-159.
13. Cleton-Jansen A-M, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ (1994) At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 9:101-107.
14. Doggett NA, Goodwin LA, Tesmer JG, Meincke LJ, Bruce DC, Clark LM, Altherr MR, Ford AA, Chi H-C, Marrone BL, Longmire MG, Lane SA, Whitmore SA, Lowenstein MG, Sutherland RD, Deaven LL, Callen DF, Moyzis RK (1995) An integrated physical map of human chromosome 16. Nature 377:335-365.
15. Doggett NA, Breuning MH, Callen DF (1996) Report on the Fourth International Workshop on Human Chromosome 16 Mapping 1995. Cytogenet Cell Genet 72:271-293.
16. Dorion-Bonnet F, Mautalen S, Hostein I, Longy M (1995) Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer 14:171-181.
17. Driouch K, Dorion-Bonnet F, Briffod M, Champeme M-H, Longy M, Lidereau R (1997) Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer 19:185-191.
18. Dutrillaux B, Gerbault-Seureau M, Zafrani B (1990) Characterization of chromosomal anomalies in human breast cancer: A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49:203-217.
19. Feunteun J, Lenoit GM (1996) BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim Biophys Acta 1242:177-180.
20. Filippova GN, Fagerlie S, Klenova E, Myers C, Dehner Y, Goodwin GH, Neiman PE, Collins S, Lobanenkov VV (1996) An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 16:2802-2813.
21. Fujino T, Risinger JI, Collins NK, Liu F-S, Nishii H, Takahashi H, Westphal E-M, Barrett JC, Sasaki H, Kohler MF, Berchuck A, Boyd J (1994) Allelotype of endometrial carcinoma. Cancer Res 54:4294-4298.
22. Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M (1995) Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J 14:1508-1519.
23. Guerin M, Barrois M, Terreir MJ, Spielmann M, Riou G (1988) Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: Correlation with poor prognosis. Oncogene Res 3:21-31.
24. Henriksson M, Luscher B (1996) Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
25. Holtrich U, Wolf G, Brauninger A, Karn T, Bohme B, Rubsamen-Waigmann H, Strebhardt K (1994) Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci USA 91:1736-1740.
26. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM (1995) Molecular genetics and chromosomal alterations in prostate cancer. Cancer 75:2004-2012.
27. Karp JE, Broder S (1995) Molecular foundations of cancer: New targets for intervention. Nature Medicine 1:309-320.
28. Kashiwaba M, Tamura G, Suzuki Y, Maesawa C, Ogasawara S, Sakata K, Satodate R (1995) Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 86:1054-1059.
29. Kihana T, Yano N, Murao S, Iketani H, Hamada K, Yano J, Matsuura S (1996) Allelic loss of chromosome 16q in endometrial cancer: Correlation with poor prognosis of patients and less differentiated histology. Jpn J Cancer Res 87:1184-1190.
30. Klenova EM, Nicolas RH, Paterson HF, Carne AF, Heath CM, Goodwin GH, Neiman PE, Lobanenkov VV (1993) CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol Cell Biol 13:7612-7624.
31. 2 promoters. Oncogene 8:1099-1102.
32. Kozman HM, Keith TP, Donis-Keller H, White RL, Weissenbach J, Dean M, Vergnaud G, Kidd K, Gusella J, Royle NJ, Sutherland GR, Mulley JC (1995) The CEPH consortium linkage map of human chromosome 16. Genomics 24:44-58.
33. Kretzner L, Blackwood EM, Eisenman RN (1992) MYC and MAX proteins possess distinct transcriptional activity. Nature 359:426-429.
34. Krumm A, Meulia T, Brunvand M, Groudine M (1992) The block to transcriptional elongation within the c-myc gene is determined in the promoter-proximal region. Genes Devel 6:2201-2213.
35. Lane HA, Nigg EA (1997) Cell-cycle control: POLO-like kinases join the outer circle. Trends Cell Biol 7:63-68.
36. Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M (1990) Genomic alterations in human breast carcinomas. Genes Chromosomes Cancer 2:191-197.
37. Lasko D, Cavenee W, Nordenskjold M (1991) Loss of constitutional heterozygosity in human cancer. Ann Rev Genet 25:281-314.
38. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R (1997) Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res 57:1058-1062.
39. Lee EY (1995) Tumor suppressor genes and their alterations in breast cancer. Semin Cancer Biol 6:119-125.
40. Levine AJ (1993) The tumor suppressor genes. Annu Rev Biochem 62:623-651.
41. Li L, Nerlov C, Prendergast G, MacGregor D, Ziff EB (1994) c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13:4070-4079.
42. Lichter P, Cremer T (1992) Chromosome analysis by nonisotopic in situ hybridization. In Rooney DE, Czepulkovski BH (eds): Human Cytogenetics: A Practical Approach. New York: Oxford University Press, pp 157-192.
43. Lindblom A, Rotstein S, Skoog L, Nordenskjöld M, Larsson C (1993) Deletion of chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res 53:3707-3711.
44. Lobanenkov VV, Nicolas RH, Adler VV, Paterson H, Klenova EM, Polotskaja AV, Goodwin GH (1990) A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5′ flanking sequence of the chicken c-myc gene. Oncogene 5:1743-1753.
45. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992) A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098.
46. Ohyashiki K, Ohyashiki JH, Kondo M, Ito H, Toyama K (1988) Chromosome change at 16q22 in nonlymphocytic leukemia: Clinical implication on leukemia patients with inv(16) versus del(16). Leukemia 2:35-40.
47. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H (1995) Allelotyping of ductal carcinoma in situ of the breast: Deletion of loci on 8p, 13q, 16q, 17p, and 17q. Cancer Res 55:3399-3405.
48. Roy AL, Carruthers C, Gutjahr T, Roeder RG (1993) Direct role for Myc in transcription initiation mediated by interaction with TFII-I. Nature 365:359-361.
49. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
50. Sanada I, Asou N, Kojima S, Kawano F, Shido T, Takatsuki K (1989) Acute myelogenous leukemia (FAB M1) associared with t(5;16) and eosinophilia: Report of an additional case. Cancer Genet Cytogenet 43:139-141.
51. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Saka OG, Nakamura Y (1990) Allelotype of breast cancer: Cumulative allele losses promote tumor progression of primary breast cancer. Cancer Res 50:7184-7189.
52. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y (1991) Allelotype of human ovarian cancer. Cancer Res 51:5118-5122.
53. Shen Y, Kozman HM, Thompson A, Phillips HA, Holman K, Nancarrow J, Lane S, Chen L-Z, Apostolou S, Doggett NA, Callen DF, Mulley JC, Sutherland GR, Richards RI (1994) A PCR-based genetic linkage map of human chromosome 16. Genomics 22:68-76.
54. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K (1993) Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889-1892.
55. Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V, Ingvarsson S (1995) High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: Correlation with high PgR and low S phase. Int J Cancer 64:112-116.
56. Strobl LH, Eick D (1992) Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J 11:3307-3314.
57. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J (1996) Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 17:225-233.
58. Thomas GA, Raffel C (1991) Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51:639-643.
59. Tsuda H, Hirohashi S (1995) Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 55:3395-3398.
60. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794.
61. Tsuda H, Callen DF, Fukutomi T, Nakamura Y, Hirohashi S (1994) Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res 54:513-517.
62. Vleminckx K, Vakaet L, Mareel M, Fiers W, van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
63. Watson PH, Pon RT, Shiu RPC (1991) Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res 51:3996-1000.
64. Weber BL (1994) Susceptibility genes for breast cancer. New Engl J Med 331:1523-1524.
65. Weinberg RA (1991) Tumor suppressor genes. Science 254:1138-1146.
66. Wolf DA, Kohlhuber E, Schulz P, Fittler F, Eick D (1992) Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone. Brit J Cancer 65:367-382.